Literature DB >> 12679765

Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation.

Marcus F Stoddard1, Pradeep Singh, Buddhadeb Dawn, Rita A Longaker.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is widely accepted as a direct cause of cardioembolic stroke from left atrial (LA) thrombus formation. However, the relationship between LA thrombus and transient ischemic attack (TIA) in patients with AF is less well established.
METHODS: Two hundred sixty-one adult patients (mean age 66 +/- 11 years, 220 men and 41 women) with AF undergoing transesophageal echocardiography (TEE) were prospectively followed up for TIA (mean duration 30.3 +/- 20.6 months).
RESULTS: LA thrombus was present in 18% (n = 46) and LA spontaneous echocardiographic contrast in 50% (n = 131) of the group. Nineteen of 261 patients had TIA during follow-up. Multivariate logistic regression showed congestive heart failure (CHF) as the only predictor of TIA when a model of clinical variables was constructed (odds ratio [OR] 2.7, P =.04). Age, sex, hypertension, and use of warfarin or aspirin were not predictors. When TEE variables were added to the model, LA thrombus became the only predictor of TIA (OR 7.7, P =.0001). Survival free of TIA (Kaplan-Meier) was significantly less (P =.0001) in patients with LA thrombus compared with those without, and the annual TIA event rate was 9.2% per year versus 1.9% per year (P <.0001), respectively.
CONCLUSIONS: To our knowledge, this is the first prospective study documenting an association between LA thrombus and TIA in patients with AF. Other TEE variables, including aortic atheromata, and clinical parameters were not independently predictive. These data support a likely thromboembolic mechanism for TIA from LA thrombus in patients with AF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679765     DOI: 10.1067/mhj.2003.91

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  17 in total

1.  Rationale and design of the RE-LATED AF--AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus--Effects of Dabigatran in patients with Atrial Fibrillation.

Authors:  Marion Ferner; Daniel Wachtlin; Torsten Konrad; Oliver Deuster; Thomas Meinertz; Stephan von Bardeleben; Thomas Münzel; Monika Seibert-Grafe; Günter Breithardt; Thomas Rostock
Journal:  Clin Res Cardiol       Date:  2015-06-25       Impact factor: 5.460

2.  Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran.

Authors:  Yasutsugu Nagamoto; Tetsuya Shiomi; Taku Matsuura; Arihide Okahara; Kaoru Takegami; Daigo Mine; Takaharu Shirahama; Yasuaki Koga; Keiki Yoshida; Kenji Sadamatsu; Kiyoshi Hayashida
Journal:  Heart Vessels       Date:  2013-09-05       Impact factor: 2.037

3.  Atrial fibrillation - patients at high risk for cerebral embolism.

Authors:  P Bernhardt; H Schmidt; T Sommer; B Lüderitz; H Omran
Journal:  Clin Res Cardiol       Date:  2006-01-12       Impact factor: 5.460

4.  Percutaneous isolation of left atrial appendage thrombus.

Authors:  Oh-Hyun Lee; Jae-Sun Uhm; Jung-Sun Kim; In-Jeong Cho; Geu-Ru Hong; Hui-Nam Pak; Yangsoo Jang
Journal:  J Cardiol Cases       Date:  2017-06-16

Review 5.  Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.

Authors:  Fabio Marsico; Milena Cecere; Antonio Parente; Stefania Paolillo; Fabiana de Martino; Santo Dellegrottaglie; Bruno Trimarco; Pasquale Perrone Filardi
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

6.  CHADS(2) and CHA(2)DS (2)-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus.

Authors:  Kristina Wasmer; Julia Köbe; Dirk Dechering; Peter Milberg; Christian Pott; Julia Vogler; Jörg Stypmann; Johannes Waltenberger; Gerold Mönnig; Günter Breithardt; Lars Eckardt
Journal:  Clin Res Cardiol       Date:  2012-09-15       Impact factor: 5.460

7.  Plasma serotonin levels and the platelet serotonin transporter.

Authors:  B Brenner; J T Harney; B A Ahmed; B C Jeffus; R Unal; J L Mehta; F Kilic
Journal:  J Neurochem       Date:  2007-05-15       Impact factor: 5.372

8.  Does Duration of Symptoms Reliably Predict Detection of Left Atrial Thrombus in Newly Diagnosed Atrial Fibrillation.

Authors:  Ali Sakhnini; Shemy Carasso; Zyad Abu Znait; Shalabi Amjad; Lisa Grossman; Ibrahim Marai
Journal:  J Atr Fibrillation       Date:  2021-08-31

9.  Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation.

Authors:  Antonio de Padua Mansur; Julio Yoshio Takada; Solange Desiree Avakian; Celia M C Strunz
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review.

Authors:  Ethan D Borre; Adam Goode; Giselle Raitz; Bimal Shah; Angela Lowenstern; Ranee Chatterjee; Lauren Sharan; Nancy M Allen LaPointe; Roshini Yapa; J Kelly Davis; Kathryn Lallinger; Robyn Schmidt; Andrzej Kosinski; Sana M Al-Khatib; Gillian D Sanders
Journal:  Thromb Haemost       Date:  2018-10-30       Impact factor: 6.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.